Cellular Origins reports that the company completed the first phase of its collaboration with Fresenius Kabi designed to help scale the manufacturing of cell and gene therapies using advanced robotics ...
GI Partners, a leading private investment firm, today announced it has completed the acquisition of the Contract Development ...
Viralgen continues its pioneering work in manufacturing science with advancements in key process understanding with analytical tools ...
New solutions include customized reagents that scale from bench to clinical trials, industrialized lentiviral vector ...
Collaboration with Stanford Medicine establishes a platform manufacturing process and analytics designed to support gene-edited hematopoietic stem cell therapies for HIV and more than 19 rare diseases ...
DUBLIN--(BUSINESS WIRE)--The "Point-of-Care Cell and Gene Therapy Manufacturing Market - A Global and Regional Analysis: Focus on Technology, Therapeutic Area, End User, and Regional Analysis - ...
Cell and gene therapy (CGT) has evolved from a niche research pursuit into a central force in biopharmaceutical innovation. By engineering living cells and genetic material to repair or replace faulty ...
Increasingly complex cell therapy modalities, including multi-edit knock-in/knockout designs, are accelerating adoption of ...
In this innovation spotlight, Tia Harmon, technical science liaison, CGT for PHC Corporation of North America (PHCNA), discusses the key challenges in CGT manufacturing and how in-line monitoring ...
Key prospects lie in R&D innovation, scaling manufacturing, and CDMO outsourcing, with a strong focus on cell therapies and gene-based interventionsDublin, April 29, 2026 (GLOBE NEWSWIRE) -- The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results